美国加州民主党参议员亚当·希夫在近期播客采访中表示，特朗普政府与科技CEO签署的AI承诺属于"非约束性"协议，缺乏实质约束力1。希夫主张建立类似美国食品药品监督管理局（FDA）的专业监管机构来制定和执行AI政策1。
希夫指出，2024年最高法院推翻了"谢夫伦尊重判例"，这使得企业可以对新监管规定提起诉讼，增加了政策制定的复杂性1。他强调需要通过立法保护创意产业的知识产权、解决数据隐私问题，并警示AI可能被用于入侵健康记录和个人隐私数据1。此外，希夫支持设立"非常狭窄的反垄断豁免"以应对大规模网络攻击威胁1。
在政治前景方面，希夫表示如果民主党重掌国会，首要优先事项应是"降低成本"而非弹劾1。他还批评国会在社交媒体监管方面表现不佳1。
California Democratic Senator Adam Schiff has criticized the Trump administration's approach to artificial intelligence governance, characterizing agreements signed with technology executives as non-binding pledges lacking meaningful enforcement mechanisms.1 Instead, Schiff advocates for establishing a dedicated regulatory agency modeled after the Food and Drug Administration to develop comprehensive AI policy.1
The senator emphasized that legislative action is necessary to protect intellectual property rights in creative industries and address data privacy concerns.1 Schiff highlighted that AI systems could be exploited to breach health records and compromise personal privacy data.1 He expressed support for narrowly tailored antitrust exemptions as a mechanism to respond to large-scale cyberattacks.1
Regarding congressional oversight of technology platforms, Schiff acknowledged that lawmakers have performed inadequately in their regulatory efforts.1 Looking ahead to potential Democratic control of Congress, he indicated that the party's primary focus should be reducing costs rather than pursuing impeachment, suggesting that oversight and investigation would take precedence.1
评论
还没有评论，欢迎留下第一条。